Latest news
Loading news…
ImmunoRx Pharma
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Wilmington, North Carolina, United States Founded 2020 For Profit
ImmunoRx Pharma develops an anti-body that treats certain types of chronic inflammatory diseases.
ImmunoRx Pharma was acquired by TVM Capital Life Science in 2021.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Patents granted
- 1
- Trademarks
- 0
- Top patent class
- Organic Chemistry
- IT spend
- $9M
Company Info
- Founded
- 2020
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- HQ
- Wilmington, North Carolina, United States
- Region
- East Coast, Southern US
- Exit date
- Jan 19, 2021
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -0.4
- Trend (90d)
- -0.4
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to ImmunoRx Pharma
Loading news…
FAQs about ImmunoRx Pharma
People who checked this page also checked these
Browse the full Acquirezy directory.